Atlas Trials

Pharmacokinetic Study of Buparlisib in Subjects With Renal Impairment.

Clinical trial NCT02048787 · COMPLETED

Trial details

NCT number
NCT02048787
Sponsor
Novartis Pharmaceuticals
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Renal Impairment
Start date
2014-03-01
Primary completion
2015-03-01
Enrollment
19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.